Kenergy Scientific Stock Performance
| MSGP Stock | USD 0.0005 0.00 0.00% |
Kenergy Scientific holds a performance score of 12 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of 7.33, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Kenergy Scientific will likely underperform. Use Kenergy Scientific information ratio and rate of daily change , to analyze future returns on Kenergy Scientific.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Kenergy Scientific are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Even with relatively unsteady technical and fundamental indicators, Kenergy Scientific reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Other Cashflows From Financing Activities | -11.7 K | |
| Price Earnings Ratio | 0.0005 |
Kenergy |
Kenergy Scientific Relative Risk vs. Return Landscape
If you would invest 0.01 in Kenergy Scientific on October 29, 2025 and sell it today you would earn a total of 0.04 from holding Kenergy Scientific or generate 400.0% return on investment over 90 days. Kenergy Scientific is currently generating 4.2328% in daily expected returns and assumes 26.4318% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Kenergy, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Kenergy Scientific Target Price Odds to finish over Current Price
The tendency of Kenergy Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.0005 | 90 days | 0.0005 | about 11.13 |
Based on a normal probability distribution, the odds of Kenergy Scientific to move above the current price in 90 days from now is about 11.13 (This Kenergy Scientific probability density function shows the probability of Kenergy Pink Sheet to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the pink sheet has the beta coefficient of 7.33 . This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Kenergy Scientific will likely underperform. In addition to that Kenergy Scientific has an alpha of 3.5104, implying that it can generate a 3.51 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Kenergy Scientific Price Density |
| Price |
Predictive Modules for Kenergy Scientific
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Kenergy Scientific. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Kenergy Scientific Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Kenergy Scientific is not an exception. The market had few large corrections towards the Kenergy Scientific's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Kenergy Scientific, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Kenergy Scientific within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 3.51 | |
β | Beta against Dow Jones | 7.33 | |
σ | Overall volatility | 0.0002 | |
Ir | Information ratio | 0.15 |
Kenergy Scientific Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Kenergy Scientific for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Kenergy Scientific can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Kenergy Scientific is way too risky over 90 days horizon | |
| Kenergy Scientific has some characteristics of a very speculative penny stock | |
| Kenergy Scientific appears to be risky and price may revert if volatility continues | |
| Kenergy Scientific currently holds 1.12 M in liabilities. Kenergy Scientific has a current ratio of 0.03, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Kenergy Scientific until it has trouble settling it off, either with new capital or with free cash flow. So, Kenergy Scientific's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Kenergy Scientific sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Kenergy to invest in growth at high rates of return. When we think about Kenergy Scientific's use of debt, we should always consider it together with cash and equity. | |
| Kenergy Scientific generates negative cash flow from operations |
Kenergy Scientific Fundamentals Growth
Kenergy Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Kenergy Scientific, and Kenergy Scientific fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Kenergy Pink Sheet performance.
| Return On Asset | 1.27 | |||
| Profit Margin | 0.15 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 1.86 M | |||
| Shares Outstanding | 1.34 M | |||
| Price To Earning | 0.07 X | |||
| Price To Sales | 4.07 X | |||
| Revenue | 726.81 K | |||
| EBITDA | 198.83 K | |||
| Total Debt | 1.12 M | |||
| Book Value Per Share | (2.21) X | |||
| Cash Flow From Operations | (361.2 K) | |||
| Earnings Per Share | 389.92 X | |||
About Kenergy Scientific Performance
Assessing Kenergy Scientific's fundamental ratios provides investors with valuable insights into Kenergy Scientific's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Kenergy Scientific is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
MedSmart Group Inc. owns and operates a professional network of MedSmart wellness centers specializing in anti-aging treatments. Its services include testosterone replacement therapy, cryogen therapy, hormone restoration, hypothyroidism, allergies, high cholesterol, hypertension, diabetes, Smart Diet, vein treatment, laser hair removal, hair loss treatment, Medi-Fast program, and erectile dysfunction treatment. Medsmart operates under Medical Care Facilities classification in the United States and is traded on OTC Exchange. It employs 4 people.Things to note about Kenergy Scientific performance evaluation
Checking the ongoing alerts about Kenergy Scientific for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Kenergy Scientific help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Kenergy Scientific is way too risky over 90 days horizon | |
| Kenergy Scientific has some characteristics of a very speculative penny stock | |
| Kenergy Scientific appears to be risky and price may revert if volatility continues | |
| Kenergy Scientific currently holds 1.12 M in liabilities. Kenergy Scientific has a current ratio of 0.03, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Kenergy Scientific until it has trouble settling it off, either with new capital or with free cash flow. So, Kenergy Scientific's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Kenergy Scientific sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Kenergy to invest in growth at high rates of return. When we think about Kenergy Scientific's use of debt, we should always consider it together with cash and equity. | |
| Kenergy Scientific generates negative cash flow from operations |
- Analyzing Kenergy Scientific's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Kenergy Scientific's stock is overvalued or undervalued compared to its peers.
- Examining Kenergy Scientific's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Kenergy Scientific's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Kenergy Scientific's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Kenergy Scientific's pink sheet. These opinions can provide insight into Kenergy Scientific's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Kenergy Pink Sheet Analysis
When running Kenergy Scientific's price analysis, check to measure Kenergy Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kenergy Scientific is operating at the current time. Most of Kenergy Scientific's value examination focuses on studying past and present price action to predict the probability of Kenergy Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kenergy Scientific's price. Additionally, you may evaluate how the addition of Kenergy Scientific to your portfolios can decrease your overall portfolio volatility.